ZNTL
Zentalis Pharmaceuticals, Inc. · Healthcare
President Cam Gallagher sold $223K of Zentalis Pharmaceuticals, Inc.
Sold$222,678
$22.27Price
10,000Shares
−2%Stake
What ZNTL did after the filing
- The stock from Mon, Feb 6 close, $22.05
- −16.7%
- S&P 500, same days
- −2.3%
Measured over 30 trading days, to the Mar 21 close.
Traded Mon, Feb 6. Filed Mon, Feb 6, 2:36 PM ET, during the session. Returns use the Feb 6 close and the Mar 21 close. Not investment advice.